csirt@kutim:~/threat-intel/cve/CVE-2020-15563

Katalog CVE

CVSS 6.5 · Medium EPSS 0,41%

Kerentanan Improper Restriction of Operations within the Bounds of a Memory Buffer pada xen, debian linux +2 lainnya. Skor CVSS 3.1 6.5 (Medium) menurut NVD.

Deskripsi (NVD)

An issue was discovered in Xen through 4.13.x, allowing x86 HVM guest OS users to cause a hypervisor crash. An inverted conditional in x86 HVM guests' dirty video RAM tracking code allows such guests to make Xen de-reference a pointer guaranteed to point at unmapped space. A malicious or buggy HVM guest may cause the hypervisor to crash, resulting in Denial of Service (DoS) affecting the entire host. Xen versions from 4.8 onwards are affected. Xen versions 4.7 and earlier are not affected. Only x86 systems are affected. Arm systems are not affected. Only x86 HVM guests using shadow paging can leverage the vulnerability. In addition, there needs to be an entity actively monitoring a guest's video frame buffer (typically for display purposes) in order for such a guest to be able to leverage the vulnerability. x86 PV guests, as well as x86 HVM guests using hardware assisted paging (HAP), cannot leverage the vulnerability.

Rincian

Terbit di NVD
7 Juli 2020
Terakhir diubah
17 Juni 2026
Status NVD
Modified
CVSS 3.1
6.5 (Medium), sumber NVD
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:C/C:N/I:N/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-119: Improper Restriction of Operations within the Bounds of a Memory Buffer
EPSS (30 hari)
0,41% peluang dieksploitasi; lebih tinggi dari 33,7% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
xen xen Versi 4.8.0 hingga 4.13.1
debian debian linux Versi 10.0
fedoraproject fedora Versi 31
fedoraproject fedora Versi 32
opensuse leap Versi 15.2

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.